Fund

NeoMed Innovation IV LP

Business Office: Oslo

Jurisdiction: Jersey


Vintage2005
Geographic FocusNorway, USA, RoW
StageVenture
Ind. FocusLife Science
Fund Size EUR 103.6m
Argentum Comitted (mill)19
Argentum Comitted (%)18.34 %
Fund ManagerNeomed Management
Portfolio companies
Name Entry date Exit date Location Industry Stage
Diagnoplex SA2008-12-09 RoWLife ScienceVenture
Creabilis Therapeutics 2008-04-01 RoWLife ScienceVenture
Minnow Medical2007-06-01 USALife ScienceVenture
Jena Valve Technology2007-08-24 USALife ScienceVenture
Santhera Pharmaceuticals2006-08-01 RoWLife ScienceVenture
Novexel2006-12-01 RoWLife ScienceVenture
NovaShunt2006-12-01 RoWLife ScienceVenture
EUSA Pharma2007-03-01 USALife ScienceVenture
Endosense2005-10-01 RoWLife ScienceVenture
Exited portfolio companies
Name Entry date Exit date Location Industry Stage
PregLem2007-06-012010-10-07RoWLife ScienceVenture
 

NeoMed Innovation IV LP fundraisings

NeoMed Innovation IV LP deals

 
 
Geographic focus
Stage
Industry
 
 

Ownership

 
18.34%
NeoMed Innovation IV LP
 
 

Latest PE Voice

Harald Mix on Nordic private equity

- 1/10/2012 10:10:00 AM
At the Argentum Conference in 2010, we asked Harald Mix, Managing Partner and Co-founder of Altor Equity Partners about the outlook for future returns in Nordic private equity.
 
 

Calendar

2012-02-07 in Stockholm

Limited Partners Brief 2012

2012-02-07 in London

LP-GP Forum Clean Energy & Sustainability

2012-02-16 in Bergen

Vestlandskonferansen

2012-02-27 in Berlin

SuperReturn International 2012

2012-03-05 in Copenhagen

Nordic Fundraising Summit
 

Market Database Search

By following this link you can explore Argentum's extensive database. Our database tracks the majority of Nordic private equity funds, managers and portfolio companies. You may also search for the latest private equity news or browse the latest insight and market statistics. Please note that Argentum only publishes publicly available information.
Copyright Argentum 2009